Chief, Fungal Pathogenesis Section, Laboratory of Clinical Immunology & Microbiology National Institute of Allergy and Infectious Diseases Bethesda, Maryland, United States
Disclosure(s):
Michail S. Lionakis, MD, ScD: No financial relationships to disclose
Learning Objectives:
Upon completion, participants will be able to describe the clinical manifestations of APS-1/APECED syndrome.
Upon completion, participants will be able to define the mechanisms of autoimmunity in APS-1/APECED patients.
Upon completion, participants will be able to describe effective therapeutic interventions for APS-1/APECED patients.
